Research

Ongoing Research:

• A Phase 1b/2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects with Severe Coronavirus Disease 2019 (COVID-19) – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• Effects of Immulina Dietary Supplementation on Innate and Adaptive Immune Measures in Normal Human Volunteers – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• Proteomic Approach to Patients with Asthma Living in Mississippi vs Minnesota – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• The Effects of Stress Perception, Anxiety, and Depression on Markers of Disease Control in Patients with Asthma – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• Rate of positive penicillin test in UMC population with documented claim of penicillin allergy in chart – Dr. Stephen LeBlanc, MD – Principal Investigator

Upcoming Research:

• Impact of Oral Immulina(TM) Supplementation on Natural Killer Cell Activities and Other Biomarkers Associated with Increasing Host Immune Resilience to Upper Respiratory Viruses in Normal Human Volunteers – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• An Open Label Trial of Transfusion of COVID-19 Convalescent Plasma (CCP) to Patients with Moderate to Severe COVID-19 – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• Identifying Stress Susceptibility with Single Nucleotide Polymorphisms – Dr. Gailen D. Marshall, Jr., MD, PhD – Principal Investigator
• The Effect of ACE Inhibitor Use on the Severity of Anaphylaxis -  Dr. Stephen LeBlanc, MD – Principal Investigator